Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06460181 · ClinicalTrials.gov registry record · Phase 4
Impact of Astaxanthin on Cognition in Recreationally Active Females
A Phase 4 study of Mental Fatigue, sponsored by University of North Alabama.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT06460181: Recruiting Phase 4 study of Mental Fatigue, sponsored by University of North Alabama.
NCT06460181 is a Phase 4 study of Mental Fatigue that is actively recruiting participants, run by University of North Alabama. The registered enrollment target is 24 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06460181, a Phase 4 study of Mental Fatigue, is actively recruiting participants, sponsored by University of North Alabama.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the protentional that the antioxidant Astaxanthin has on mitigating cognitive decline following mental fatigue.
Primary Outcome
How quickly the participant reacts to a stimulus. Expressed in millaseconds. The lower the number, the faster the participants reacted to the given stimulus. All test were conducted on an iPad using the cognitive software SOMANPT.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Astaxanthin
- DIETARY_SUPPLEMENT Placebo
Study Locations (1)
Alabama
- University of North Alabama - Florence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2024-08-01 |
| Est. Completion | 2024-11-01 |
| Phase | Phase 4 |
What NCT06460181 shows while recruiting
NCT06460181 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Mental Fatigue appearing as the primary indexed condition, and to 2 interventions - of which Astaxanthin is the first listed.
NCT06460181 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT06460181 about?
NCT06460181 is a clinical study titled "Impact of Astaxanthin on Cognition in Recreationally Active Females". The purpose of this study is to examine the protentional that the antioxidant Astaxanthin has on mitigating cognitive decline following mental fatigue.
What is the current status of trial NCT06460181?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2024-08-01. Estimated completion is 2024-11-01.
What conditions does trial NCT06460181 study?
This clinical trial studies the following conditions: Mental Fatigue.
What interventions are being tested in trial NCT06460181?
The interventions under investigation include: Astaxanthin (DIETARY_SUPPLEMENT), Placebo (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06460181?
This trial is sponsored by University of North Alabama, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06460181 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mental Fatigue
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06460181's enrollment target sits among peer trials
24 1699th of 2000 higher than 277 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI